SAM
ANIP icon

Smartleaf Asset Management’s ANI Pharmaceuticals ANIP Stock Holding History

Smartleaf Asset Management’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.54K Sell
48
-155
-76% -$12.1K ﹤0.01% 2789
2025
Q4 		$16.1K Hold
203
– – ﹤0.01% 2152
2025
Q3 		$18.7K Sell
203
-8
-4% -$652 ﹤0.01% 1839
2025
Q2 		$13.8K Sell
211
-2
-0.9% -$130 ﹤0.01% 1708
2025
Q1 		$14.4K Sell
213
-13
-6% -$776 ﹤0.01% 1769
2024
Q4 		$12.3K Buy
226
+184
+438% +$10.6K ﹤0.01% 1909
2024
Q3 		$2.47K Buy
42
+17
+68% +$1.04K ﹤0.01% 2412
2024
Q2 		$1.58K Buy
+25
New +$1.62K ﹤0.01% 2307

Other funds holding ANIP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
GAM
Goldentree Asset Management New York $1.69B AUM 10.69% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Smartleaf Asset Management's ANIP Position: Q1 2026 in Review

Smartleaf Asset Management reduced its ANI Pharmaceuticals (ANIP) stake by 76% in Q1 2026, selling an estimated $12.1K and leaving 48 shares worth $3.54K. The position accounts for ﹤0.01% of the portfolio, ranked #2789.

Smartleaf Asset Management first reported a position in ANIP in Q2 2024 and has held it in 8 quarters since. The position peaked at $18.7K in Q3 2025. 280 funds tracked by Wall St. Rank hold ANIP as of Q1 2026.

  • Smartleaf Asset Management held 48 shares of ANI Pharmaceuticals worth $3.54K as of Q1 2026.
  • Smartleaf Asset Management sold 155 ANI Pharmaceuticals shares in Q1 2026, an estimated $12.1K.
  • ANI Pharmaceuticals made up ﹤0.01% of Smartleaf Asset Management's portfolio in Q1 2026, its #2789 holding.
  • Smartleaf Asset Management first reported a position in ANI Pharmaceuticals in Q2 2024 and has held it in 8 quarters since.
  • Smartleaf Asset Management's ANI Pharmaceuticals position peaked at $18.7K in Q3 2025.
  • 280 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q1 2026.

Based on Smartleaf Asset Management's 13F filing for Q1 2026, filed 15 May 2026.